NUTX Nutex Health Inc. - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders

At the annual meeting of stockholders of Nutex Health Inc. (the "Company”) held on April 23, 2026, there were 5,628,591 shares of the Company’s common stock, par value $0.001 per share, eligible to vote, of which 3,900,175 shares, or approximately 69.29% of the Company’s shares eligible to vote, were voted. The matters voted upon, the number of votes cast for or against, and the number of abstentions and broker non-votes, each rounded to the nearest whole share, were as stated below:

1. Each of our seven director nominees was elected for an approximate one-year term expiring at the 2027 annual meeting of stockholders.

Nominee

For

Withheld

Broker Non-Votes

Thomas T. Vo

2,554,009

89,198

1,256,968

Warren Hosseinion

2,512,649

130,558

1,256,968

Cheryl Grenas

2,555,905

87,302

1,256,968

Michael L. Reed

2,556,927

86,280

1,256,968

Scott J. Saunders

2,532,892

110,315

1,256,968

Kelvin Spears

2,525,003

118,204

1,256,968

Frank E. Jaumot

2,623,902

19,305

1,256,968

2. The compensation of our named executive officers was approved, on an advisory basis.

For

Against

Abstain

Broker Non-Votes

2,505,375

126,612

11,220

1,256,968

3. Grant Thornton LLP was ratified as our independent registered public accounting firm for the year ending December 31, 2026.

For

Against

Abstain

Broker Non-Votes

3,841,817

25,441

32,917

—